Forty-Second Annual Symposium: Wednesday, September 20, 2023
Description: This program is designed to provide attendees with practical information about recent developments, current practices, controversies and laboratory management issues relative to transfusion medicine.
Who Should Attend: This program will be of interest to all healthcare providers who participate in the collection, production, transfusion and monitoring of blood products.
Upon the completion of this activity, participants should be able to:
- Discuss the challenges healthcare center-based cellular therapy laboratories must navigate in supporting cellular therapies manufactured off-site.
- Describe to other blood center and transfusion medicine team members how the ADVANCE study enrollment and results support the move to an individual donor assessment approach to donor selection in the US, and to communicate the limitations of this study to others.
- Identify recommendations and contraindications for yellow fever vaccine receipt.
- Describe significant events in the history of American Red Cross Blood Services/Transfusion Medicine and identify current blood bank industry trends likely to impact collection centers in the future.
- Explain the role of virus-specific cytotoxic T-lymphocytes (CTLs) in controlling viral infections and describe the CTL-mediated killing of infected cells and how it relates to viral clearance.
- Develop appropriate patient and donor care strategies from examples described during clinical vignette presentations.
Level of Instruction: Intermediate to Advanced
This program has a pending application for continuing education credits.